Abstract:BACKGROUND In the elderly the most common cause of hospitalisation and the leading cause of death is heart failure (HF). AIM The purpose was to determine prognostic factors in chronic HF (CHF) in octogenarians and nonagenarians. METHODS The analysis included 197 consecutive patients over 80 years old (mean age 83.63 ± 3.01 years; 46.19% men) hospitalised in 2010-2013 due to CHF. Sixty-two parameters were investigated, such as: age, gender, New York Heart Asso-ciation functional class, body mass index, blood pressure, other comorbidities, the parameters of the 12-lead resting electro-cardiography and the echocardiography, the results of basic laboratory tests, and selected biomarkers, including N-terminal pro-B-type natriuretic peptide, high-sensitive troponin T (hs-TnT), and high-sensitive C-reactive protein. Participants remained in a prospective follow-up for 12 months. We defined the primary endpoint as death due to cardiovascular causes and the composite endpoint, which consisted of: death due to cardiovascular causes and/or hospitalisation for exacerbation of CHF. Follow-up concerning the deaths was performed in 189 patients, composite endpoint in 168 and hospitalisation in 166. The uni- and multivariate logistic regression stepwise analysis was performed for the entire population, according to left ventricular ejection fraction (LVEF < 45% and ≥ 45%) and in the group with glomerular filtration rate (GFR) < 60 mL/min. RESULTS Patients who died constituted 11.1% of the study population (21/189). In multivariate analysis four variables were independently associated with the primary endpoint: GFR (OR = 0.92), hypertension (OR = 0.19), lung diseases (OR = 9.36), and vascular diseases (OR = 6.07). In turn, in the group of patients who reached the composite endpoint (55/168; 32.7%), the only statistically significant independent variable was anaemia (OR = 4.71). In the subpopulation of patients with LVEF < 45% the prognostics for each endpoint were vascular diseases and lung diseases, and they increased the risk from 10- to 24-fold. In the subgroup of patients with LVEF ≥ 45% the independent variable associated with the composite endpoint was haemoglobin (OR = 0.61), in turn for death the prognostics were: white blood cell count, hs-TnT, and vascular diseases (respectively OR = 1.30; OR = 1.04; OR = 3.96). In the population with GFR < 60 mL/min variables with prognostic importance for the composite endpoint were red blood cell parameters: red blood cell distribution width (OR = 1.42) and anaemia (OR = 3.79), while for occurrence of death they were the same as for the entire population - vascular (OR = 5.16) and lung diseases (OR = 4.72). CONCLUSIONS In patients over 80 years old with CHF, comorbidities are of important prognostic value for annual prognosis. The most aggravating factor in studied subgroups was lung disease.

Utilization of medication-assistance programs for medically uninsured patients: one public teaching hospital's experience.

Small intestine-targeted endoscopic bariatrics: current status and future perspectives.

Medical image. Hydrocolpos in a child.

Novel Surgical Interventions for the Treatment of Obesity

An update on less invasive and endoscopic techniques mimicking the effect of bariatric surgery

Endoscopic Bariatric and Metabolic Therapies for Liver Disease: Mechanisms, Benefits, and Associated Risks

From surgery to endoscopy: the evolution of the bariatric discipline

The Future of Endobariatrics: Bridging the Gap

The effects of aflatoxin B 1 and aminoazodye carcinogens on rat and mouse liver nuclear acid deoxyribonuclease.

Surgical management of obesity

A commentary review on endoscopic sleeve gastroplasty: Indications, outcomes and future implications

Annual prognostic factors in chronic heart failure in patients over 80 years old.

Bariatrics and endoscopic therapies for the treatment of metabolic disease: Past, present, and future

Update on Endoscopic Treatments for Obesity

Combination Therapies: Anti-Obesity Medications and Endoscopic Bariatric Procedures

Endoscopic Management of Bariatric Surgery Complications: Fistulas, Leaks, and Ulcers

S2085 Comparing the Efficacy of Endoscopic Bariatric Interventions and GLP-1 Agonists to Endoscopic Bariatric Interventions Alone in Weight Loss; A Systematic Review and Meta-analysis

Novel Devices for Endoscopic Suturing: Past, Present, and Future

American Society for Gastrointestinal Endoscopy–European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity

Intra-gastric balloons - The past, present and future

Design and Methodological Aspects